The Application and Feasibility of Using Routine Data Sources for Long-term Cancer Clinical Trial Follow-up

被引：4

作者：

Bhattacharya, I. S. ^{[1
]}

Morden, J. P. ^{[1
]}

Griffin, C. ^{[1
]}

Snowdon, C. ^{[1
]}

Brannan, R. ^{[2
]}

Bliss, J. M. ^{[1
]}

Kilburn, L. ^{[1
]}

机构：

[1] Inst Canc Res, Clin Trials & Stat Unit, London SM2 5NG, England

[2] Publ Hlth England, Off Data Release, London, England

来源：

CLINICAL ONCOLOGY | 2017年 / 29卷 / 12期

关键词：

HEALTH;

D O I：

10.1016/j.clon.2017.10.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：796 / 798

页数：3

共 6 条

[1] Innovative Solutions for Clinical Trial Follow-up: Adding Value from Nationally Held UK Data [J].

Appleyard, S. E. ;

Gilbert, D. C. .

CLINICAL ONCOLOGY, 2017, 29 (12) :789-795

[2]

Cameron D, 2017, LANCET ONCOL, V18, P929, DOI [10.1016/s1470-2045(17)30404-7, 10.1016/S1470-2045(17)30404-7]

[3]

Kilburn L, 2012, NAT CANC RES I NCRI

[4] It's PRIMETIME. Postoperative Avoidance of Radiotherapy: Biomarker Selection of Women at Very Low Risk of Local Recurrence [J].

Kirwan, C. C. ;

Coles, C. E. ;

Bliss, J. .

CLINICAL ONCOLOGY, 2016, 28 (09) :594-596

[5] National Health Service Cancer Strategy for England: Where Are We Now? [J].

Kumar, H. S. .

CLINICAL ONCOLOGY, 2016, 28 (05) :277-278

[6] Evidence-based public health: Moving beyond randomized trials [J].

Victora, CG ;

Habicht, JP ;

Bryce, J .

AMERICAN JOURNAL OF PUBLIC HEALTH, 2004, 94 (03) :400-405

← 1 →